| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/26/2013 | WO2013140342A1 Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists |
| 09/26/2013 | WO2013140148A1 Quinazoline compounds and their use in therapy |
| 09/26/2013 | WO2013139941A1 Pharmaceutical combination products for parkinson's disease |
| 09/26/2013 | WO2013139931A1 Composition for use in the treatment of neurodegenerative diseases with parkinsonian syndromes |
| 09/26/2013 | WO2013139882A1 Pyrazolopyridines for treatment of parkinsons disease |
| 09/26/2013 | WO2013139861A1 Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| 09/26/2013 | WO2013139730A1 Chemical compounds |
| 09/26/2013 | WO2013139387A1 Stabilized pharmaceutical compositions comprising rasagiline salts |
| 09/26/2013 | WO2013139300A1 Recombinant lentiviral vector formulation |
| 09/26/2013 | WO2013139209A1 Topiramate sustained-release pharmaceutical composition, method for preparing same, and use thereof |
| 09/26/2013 | WO2013139195A1 Huperzine a polycrystal, preparation method therefor, pharmaceutical composition comprising polycrystal and use thereof |
| 09/26/2013 | WO2013052885A9 Prophylactic and post-acute use of progesterone in conjunction with its enantiomer for use in treatment of traumatic brain injuries |
| 09/26/2013 | US20130251812 Sequestered antagonist formulations |
| 09/26/2013 | US20130251789 Tamper-resistant oral opioid agonist formulations |
| 09/26/2013 | US20130251760 Transdermal Analgesic Systems with Reduced Abuse Potential |
| 09/25/2013 | EP2641907A1 Preparation of modulators of 5-HT receptors |
| 09/25/2013 | EP2641891A1 Pkc- activator |
| 09/25/2013 | EP2641617A1 Methods and compositions for mitochondrial replacement therapy |
| 09/25/2013 | EP2641603A1 Pharmaceutical formulation having neuroprotective activity |
| 09/25/2013 | EP2640737A1 Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| 09/25/2013 | EP2640731A1 Imidazole derivatives as pde10a enzyme inhibitors |
| 09/25/2013 | EP2640709A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 09/25/2013 | EP2640703A1 Heterocyclic compounds as imaging probes of tau pathology |
| 09/25/2013 | EP2640687A1 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS |
| 09/25/2013 | EP2640407A1 Method for increasing neprilysin expression and activity |
| 09/25/2013 | EP2640395A2 Treatment of addiction and impulse-control disorders using pde7 inhibitors |
| 09/25/2013 | EP2640379A2 Low dose cannabinoid medicaments |
| 09/25/2013 | EP2640376A2 Caffeic acid derivatives and their use in improving neuronal cell viability |
| 09/25/2013 | EP2640374A1 Apomorphine by pulmonary inhalation, oprionally in combination with l-dopa or a dopamine agonist for use in the treatment of parkinson |
| 09/25/2013 | EP2640358A1 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
| 09/25/2013 | CN103328487A Imidazole derivatives as pde10a enzyme inhibitors |
| 09/25/2013 | CN103328486A Fused aminodihydrothiazine derivatives useful as BACE inhibitors |
| 09/25/2013 | CN103328477A Pharmaceutical composition comprising pyridone derivatives |
| 09/25/2013 | CN103328468A Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease |
| 09/25/2013 | CN103328467A Hydantoin derivatives useful as KV3 inhibitors |
| 09/25/2013 | CN103328451A Compounds for the reduction of beta-amyloid production |
| 09/25/2013 | CN103328433A Analgesic compounds, methods, and formulations |
| 09/25/2013 | CN103327973A Therapeutic use of compounds |
| 09/25/2013 | CN103327970A Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form |
| 09/25/2013 | CN103320472A Method for producing endomorphin 2 via high-efficiency expression, and application for same |
| 09/25/2013 | CN103320400A Virus AAVHSTF expressing iron nano particles and temperature sensitive channel and use |
| 09/25/2013 | CN103320399A Virus AAVHTF for expressing iron nano particles and temperature-sensitive channels and application |
| 09/25/2013 | CN103320398A Virus AAVTF for expressing iron nano particles and temperature-sensitive channels and application |
| 09/25/2013 | CN103320397A Virus LVTF expressing iron nano particles and temperature sensitive channel and use |
| 09/25/2013 | CN103320396A Virus AAVSMTF for expressing iron nano particles and temperature-sensitive channels and application |
| 09/25/2013 | CN103320395A Virus LVSTF for expressing iron nano particles and temperature-sensitive channels and application |
| 09/25/2013 | CN103320296A Health-care honey wine and its preparation method |
| 09/25/2013 | CN103320285A A mulberry-soybean health-care wine and a preparation method thereof |
| 09/25/2013 | CN103320284A A cactus-shiitake health-care wine and a preparation method thereof |
| 09/25/2013 | CN103320270A Method for producing base liquor by combination of mouldy bran prepared from rhizopus and yeast strains and Daqu and medicinal liquor |
| 09/25/2013 | CN103319609A Human basic fibroblast growth factor (hbFGF) fusion gene and application thereof |
| 09/25/2013 | CN103319508A Cellular structural supramolecular compound with drug molecule serving as ligand and preparation method of cellular structural supramolecular compound |
| 09/25/2013 | CN103319500A Novel benzodiazepine sedative hypnotic drug |
| 09/25/2013 | CN103319486A Method for synthesis of 4H-imidazo[1, 5-a][1, 4]benzodiazepine, especially midazolam |
| 09/25/2013 | CN103319479A Rheinic acid berberine ion pair compound, preparation method and applications |
| 09/25/2013 | CN103319445A Crystal structure of SGLT2 inhibitor and preparation method of crystal structure |
| 09/25/2013 | CN103319409A Edaravone compound, medicinal composition thereof, and preparation methods of compound and composition |
| 09/25/2013 | CN103316356A Recombinant lentivirus vector preparation |
| 09/25/2013 | CN103316346A Pharmaceutical composition for treating epilepsy |
| 09/25/2013 | CN103316319A Traditional Chinese medicine for treating facial neuritis |
| 09/25/2013 | CN103316304A Insomnia treatment plaster |
| 09/25/2013 | CN103316289A Chinese patent medicine for treating hepatic depression syndrome type moodiness during menstruation |
| 09/25/2013 | CN103316285A Traditional Chinese medicine for drug rehabilitation |
| 09/25/2013 | CN103316255A Children health-care product and its preparation method |
| 09/25/2013 | CN103316248A Traditional Chinese medicinal preparation for adjuvant therapy of depression and preparation method thereof |
| 09/25/2013 | CN103316244A Traditional Chinese medicine for treating hypertension |
| 09/25/2013 | CN103316234A Health product for preventing and improving Alzheimer's disease and applications thereof |
| 09/25/2013 | CN103316231A Capsule for calming liver wind and preparation method thereof |
| 09/25/2013 | CN103316230A Headache treatment spray |
| 09/25/2013 | CN103316228A Scorpio unsting wine |
| 09/25/2013 | CN103316227A Medicine composition for treating rheumatic diseases in muscles and bones and preparation method thereof |
| 09/25/2013 | CN103316225A Traditional Chinese medicine for treating epilepsy and preparation method thereof |
| 09/25/2013 | CN103316224A Traditional Chinese medicine preparation with functions of nourishing liver and kidney, replenishing essence and blood, invigorating brain and improving eyesight |
| 09/25/2013 | CN103316207A Memory aging resistance nature drug compound prescription |
| 09/25/2013 | CN103316169A Traditional Chinese medicine composition, preparation method therefor and applications in treatment of insomnia |
| 09/25/2013 | CN103316149A Medicine for treating early-stage Alzheimer's disease |
| 09/25/2013 | CN103316144A Chinese medicine composition capable of invigorating qi and blood, nourishing yin and yang, improving immunity, resisting to fatigue and inhibiting thrombogenesis |
| 09/25/2013 | CN103316130A Traditional Chinese medicine composition for treating trigeminal neuralgia |
| 09/25/2013 | CN103316127A Use of traditional Chinese medicine in catatonic schizophrenia treatment medicines |
| 09/25/2013 | CN103316126A Traditional Chinese medicine for treating schizophrenia |
| 09/25/2013 | CN103316125A Use of traditional Chinese medicine in preparation of hebephrenic schizophrenia treatment medicines |
| 09/25/2013 | CN103316111A Application of medicine in preparation of hebephrenic schizophrenia treatment medicines |
| 09/25/2013 | CN103316110A Use of medicine in simple schizophrenia treatment medicines |
| 09/25/2013 | CN103316109A Use of medicine in catatonic schizophrenia treatment medicines |
| 09/25/2013 | CN103316104A Chinese medicinal composition treating facial nerve paralysis |
| 09/25/2013 | CN103316087A Myristica fragrans five-medicine effective part and, and preparation method, quality detection method and application thereof |
| 09/25/2013 | CN103316086A Tibetan medicine for treating influenza and preparation method thereof |
| 09/25/2013 | CN103316078A Sleep aiding and cooling patch and preparation method thereof |
| 09/25/2013 | CN103316067A Medicine for treating headache and preparation method thereof |
| 09/25/2013 | CN103316029A Application of Polyflavanostilbene A in preparation of medicine for treating Alzheimer disease |
| 09/25/2013 | CN103316027A Application of catalpol and retinoic acid medicine composition in preparing medicine used for preventing or treating white matter damage |
| 09/25/2013 | CN103316026A Combined product containing phentermine and topiramate, and preparation method thereof |
| 09/25/2013 | CN103316025A Application of p-hydroxyl acetophenone glycosidase to medicine for autoimmunity disease and transplant rejection disease |
| 09/25/2013 | CN103316020A Applications of demethoxyviridin in preparing Amyloid-beta aggregation inhibitor |
| 09/25/2013 | CN103316019A Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| 09/25/2013 | CN103316016A Pharmaceutical composition containing carbamazepine and application thereof |
| 09/25/2013 | CN103316007A Application of Myriberine A in preparation of anti-hypoxic drug |
| 09/25/2013 | CN103315989A Pharmaceutical composition |
| 09/25/2013 | CN103315987A Pharmaceutical composition for treating epilepsy |
| 09/25/2013 | CN103315983A Rasagiline preparation and preparation method thereof |